Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antigen Presentation by B Cells in Multiple Sclerosis.

Literature DB >> 33503348

Antigen Presentation by B Cells in Multiple Sclerosis.

Scott S Zamvil¹, Stephen L Hauser¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2021 PMID： 33503348 PMCID： PMC8029120 DOI： 10.1056/NEJMcibr2032177

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

× No keyword cloud information.

8 in total

1. Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.

Authors: Simone M Brändle; Birgit Obermeier; Makbule Senel; Jessica Bruder; Reinhard Mentele; Mohsen Khademi; Tomas Olsson; Hayrettin Tumani; Wolfgang Kristoferitsch; Friedrich Lottspeich; Hartmut Wekerle; Reinhard Hohlfeld; Klaus Dornmair
Journal: Proc Natl Acad Sci U S A Date: 2016-06-20 Impact factor: 11.205

2. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

Authors: Stephen L Hauser; Amit Bar-Or; Giancarlo Comi; Gavin Giovannoni; Hans-Peter Hartung; Bernhard Hemmer; Fred Lublin; Xavier Montalban; Kottil W Rammohan; Krzysztof Selmaj; Anthony Traboulsee; Jerry S Wolinsky; Douglas L Arnold; Gaelle Klingelschmitt; Donna Masterman; Paulo Fontoura; Shibeshih Belachew; Peter Chin; Nicole Mairon; Hideki Garren; Ludwig Kappos
Journal: N Engl J Med Date: 2016-12-21 Impact factor: 91.245

3. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.

Authors:
Journal: Science Date: 2019-09-27 Impact factor: 47.728

Review 4. Multiple Sclerosis.

Authors: Daniel S Reich; Claudia F Lucchinetti; Peter A Calabresi
Journal: N Engl J Med Date: 2018-01-11 Impact factor: 91.245

5. Ofatumumab versus Teriflunomide in Multiple Sclerosis.

Authors: Stephen L Hauser; Amit Bar-Or; Jeffrey A Cohen; Giancarlo Comi; Jorge Correale; Patricia K Coyle; Anne H Cross; Jerome de Seze; David Leppert; Xavier Montalban; Krzysztof Selmaj; Heinz Wiendl; Cecile Kerloeguen; Roman Willi; Bingbing Li; Algirdas Kakarieka; Davorka Tomic; Alexandra Goodyear; Ratnakar Pingili; Dieter A Häring; Krishnan Ramanathan; Martin Merschhemke; Ludwig Kappos
Journal: N Engl J Med Date: 2020-08-06 Impact factor: 91.245

6. Memory B Cells Activate Brain-Homing, Autoreactive CD4⁺ T Cells in Multiple Sclerosis.

Authors: Ivan Jelcic; Faiez Al Nimer; Jian Wang; Verena Lentsch; Raquel Planas; Ilijas Jelcic; Aleksandar Madjovski; Sabrina Ruhrmann; Wolfgang Faigle; Katrin Frauenknecht; Clemencia Pinilla; Radleigh Santos; Christian Hammer; Yaneth Ortiz; Lennart Opitz; Hans Grönlund; Gerhard Rogler; Onur Boyman; Richard Reynolds; Andreas Lutterotti; Mohsen Khademi; Tomas Olsson; Fredrik Piehl; Mireia Sospedra; Roland Martin
Journal: Cell Date: 2018-08-30 Impact factor: 41.582

7. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.

Authors: K W Wucherpfennig; J L Strominger
Journal: Cell Date: 1995-03-10 Impact factor: 41.582

8. HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.

Authors: Jian Wang; Ivan Jelcic; Lena Mühlenbruch; Veronika Haunerdinger; Nora C Toussaint; Yingdong Zhao; Carolina Cruciani; Wolfgang Faigle; Reza Naghavian; Magdalena Foege; Thomas M C Binder; Thomas Eiermann; Lennart Opitz; Laura Fuentes-Font; Richard Reynolds; William W Kwok; Julie T Nguyen; Jar-How Lee; Andreas Lutterotti; Christian Münz; Hans-Georg Rammensee; Mathias Hauri-Hohl; Mireia Sospedra; Stefan Stevanovic; Roland Martin
Journal: Cell Date: 2020-10-21 Impact factor: 41.582

8 in total

9 in total

Review 1. Biological Sex As a Critical Variable in CD4⁺ Effector T Cell Function in Preclinical Models of Multiple Sclerosis.

Authors: Muhammad Umair; Mohamed Reda Fazazi; Manu Rangachari
Journal: Antioxid Redox Signal Date: 2022-01-04 Impact factor: 7.468

2. The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization Study.

Authors: Di He; Liyang Liu; Dongchao Shen; Peng Zou; Liying Cui
Journal: Front Immunol Date: 2022-05-10 Impact factor: 8.786

3. Anti-CD20 Depletes Meningeal B Cells but Does Not Halt the Formation of Meningeal Ectopic Lymphoid Tissue.

Authors: Rosa Margareta Brand; Verena Friedrich; Jolien Diddens; Monika Pfaller; Francesca Romana de Franchis; Helena Radbruch; Bernhard Hemmer; Katja Steiger; Klaus Lehmann-Horn
Journal: Neurol Neuroimmunol Neuroinflamm Date: 2021-05-21

4. Specific hypomethylation programs underpin B cell activation in early multiple sclerosis.

Authors: Qin Ma; Stacy J Caillier; Shaun Muzic; Michael R Wilson; Roland G Henry; Bruce A C Cree; Stephen L Hauser; Alessandro Didonna; Jorge R Oksenberg
Journal: Proc Natl Acad Sci U S A Date: 2021-12-21 Impact factor: 12.779

Review 5. The Neuroimmunology of Multiple Sclerosis: Fictions and Facts.

Authors: Andrew R Pachner
Journal: Front Neurol Date: 2022-02-07 Impact factor: 4.003

Review 6. Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.

Authors: Isaac T W Harley; Kristen Allison; R Hal Scofield
Journal: Front Immunol Date: 2022-08-24 Impact factor: 8.786

Antigen Presentation by B Cells in Multiple Sclerosis.

1. Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.

2. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

3. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.

Review 4. Multiple Sclerosis.

5. Ofatumumab versus Teriflunomide in Multiple Sclerosis.

6. Memory B Cells Activate Brain-Homing, Autoreactive CD4⁺ T Cells in Multiple Sclerosis.

7. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.

8. HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.

Review 1. Biological Sex As a Critical Variable in CD4⁺ Effector T Cell Function in Preclinical Models of Multiple Sclerosis.

2. The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization Study.

3. Anti-CD20 Depletes Meningeal B Cells but Does Not Halt the Formation of Meningeal Ectopic Lymphoid Tissue.

4. Specific hypomethylation programs underpin B cell activation in early multiple sclerosis.

Review 5. The Neuroimmunology of Multiple Sclerosis: Fictions and Facts.

Review 6. Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.

Review 7. Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis.

Review 8. Functional immune cell-astrocyte interactions.

9. Autoimmunity to annexin A2 predicts mortality among hospitalised COVID-19 patients.

Review 4. Multiple Sclerosis.

Review 1. Biological Sex As a Critical Variable in CD4+ Effector T Cell Function in Preclinical Models of Multiple Sclerosis.

Review 5. The Neuroimmunology of Multiple Sclerosis: Fictions and Facts.

Review 6. Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.

Review 7. Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis.

Review 8. Functional immune cell-astrocyte interactions.

Review 1. Biological Sex As a Critical Variable in CD4⁺ Effector T Cell Function in Preclinical Models of Multiple Sclerosis.